Lexaria Bioscience Corp. (NASDAQ:LEXXW) Short Interest Down 41.2% in February

Lexaria Bioscience Corp. (NASDAQ:LEXXW) was the target of a large drop in short interest in the month of February. As of February 28th, there was short interest totalling 2,000 shares, a drop of 41.2% from the February 13th total of 3,400 shares. Based on an average trading volume of 9,100 shares, the short-interest ratio is presently 0.2 days.

Lexaria Bioscience Stock Performance

Shares of NASDAQ LEXXW traded up $0.06 during midday trading on Friday, hitting $0.26. 11,005 shares of the company’s stock were exchanged, compared to its average volume of 13,173. Lexaria Bioscience has a twelve month low of $0.16 and a twelve month high of $2.07. The stock’s 50 day moving average price is $0.39 and its 200-day moving average price is $0.69.

About Lexaria Bioscience

Lexaria Bioscience Corp. operates as a biotechnology company. It develops and out-licenses its patented drug delivery technology, DehydraTECH, which combines lipophilic molecules or active pharmaceutical ingredients with specific long-chain fatty acids and carrier compounds that improve the way they enter the bloodstream, increasing their effectiveness and allowing for lower overall dosing while promoting healthier oral ingestion methods.